HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Medullary thyroid carcinoma and hormones.

Abstract
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor. The identification of calcitonin as a specific and sensitive marker in 1968 determined a special interest of endocrinologists. Many hormones have been isolated in MTC tumors. Calcitonin, prostaglandins and somatostatin are of particular interest. Calcitonin is not only a marker, but is indicative of tumor size and prognosis. Moreover the presence of calcitonin receptors in MTC could have a role in the proliferation of this tumor. Somatostatin and the large use of somatostatin analogs in the treatment of neuroendocrine tumors raise the hope that these drugs could be effective in MTC patients. Unfortunately, the benefits of these treatments is not validated. More interestingly, nonsteroidal anti-inflammatory drugs could be of interest in this tumor by comparison of their use in colorectal polyps. By inhibiting Cox or inducing 15 PGDH enzymes, we have demonstrated in vitro its effectiveness. Thus, hormones in MTC are not only markers but probably mediate biological effects involved in tumor growth.
AuthorsRégis Cohen, Virginie Quidville, Hélène Bihan
JournalAnnales de medecine interne (Ann Med Interne (Paris)) Vol. 154 Issue 2 Pg. 109-16 (Mar 2003) ISSN: 0003-410X [Print] France
PMID12746649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers, Tumor
  • Hormones
  • Prostaglandin Antagonists
  • Prostaglandins
  • Somatostatin
  • Calcitonin
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Biomarkers, Tumor (blood)
  • Calcitonin (blood)
  • Carcinoma, Medullary (diagnosis, drug therapy, metabolism)
  • Hormones (therapeutic use)
  • Humans
  • Prostaglandin Antagonists (therapeutic use)
  • Prostaglandins (metabolism)
  • Somatostatin (analogs & derivatives, therapeutic use)
  • Thyroid Neoplasms (diagnosis, drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: